CN Stock MarketDetailed Quotes

688710 Shanghai InnoStar Bio-tech

Watchlist
  • 0.00
  • 0.000.00%
Market Closed Aug 28 09:30 CST
0Market Cap0.00P/E (TTM)

Shanghai InnoStar Bio-tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Money funds
--988.48M
-7.69%1.16B
96.42%1.25B
--1.14B
221.58%638.77M
-5.63%198.64M
--210.48M
Notes receivable and accounts receivable
--228.3M
24.31%223.82M
66.96%180.06M
--146.25M
238.95%107.84M
-18.87%31.82M
--39.22M
-Notes receivable
----
--11.21M
----
----
-38.78%1.34M
--2.19M
----
-Accounts receivable
--228.3M
18.08%212.62M
69.06%180.06M
--146.25M
259.47%106.5M
-24.45%29.63M
--39.22M
Other receivables (including interest and dividends)
--18.68M
193.95%17.81M
-56.22%6.06M
--5.63M
277.16%13.84M
12.45%3.67M
--3.26M
-Other receivable
--18.68M
193.95%17.81M
-56.22%6.06M
--5.63M
277.16%13.84M
12.45%3.67M
--3.26M
Contractual assets
--85.73M
4.31%50.09M
51.66%48.02M
--44.13M
108.17%31.66M
37.21%15.21M
--11.08M
Advance payment
--12.54M
-48.07%12.86M
-33.90%24.77M
--68.42M
24.43%37.47M
660.14%30.12M
--3.96M
Inventories
--379.86M
4.30%510.54M
23.34%489.47M
--423M
86.32%396.85M
84.19%212.99M
--115.63M
Other current assets
--14.45M
30.27%12.64M
-66.64%9.7M
--10.4M
5.88%29.09M
7.31%27.48M
--25.6M
Total current assets
--1.73B
-1.33%1.99B
60.31%2.01B
--1.84B
141.49%1.26B
27.04%519.92M
--409.25M
Non Current assets
Fixed assets
--213.27M
5.24%219.13M
20.33%208.23M
--187.59M
32.67%173.06M
22.68%130.44M
--106.32M
Constru in process
--202.23M
14,621.89%40.75M
-7.39%276.77K
--10.82M
--298.87K
----
----
Productive biological assets
--25.61M
48.08%28.31M
-37.26%19.12M
--24.58M
70.66%30.47M
--17.86M
----
Intangible assets
--107.37M
903.73%109.47M
102.32%10.91M
--6.36M
63.24%5.39M
-21.06%3.3M
--4.18M
Long deferred expense
--73.73M
-5.57%77.02M
10.56%81.57M
--70.7M
-6.71%73.78M
-6.77%79.08M
--84.82M
Deferred tax assets
--15.02M
69.81%13.21M
2.57%7.78M
--10.2M
76.85%7.58M
324.42%4.29M
--1.01M
Usufruct assets
--187.34M
-8.26%198.98M
-9.57%216.9M
--230.04M
161.86%239.86M
--91.6M
----
Other non current assets
--92.35M
68.92%102.57M
265.26%60.72M
--45.97M
266.27%16.62M
57.35%4.54M
--2.88M
Total non current assets
--916.92M
30.38%789.45M
10.68%605.51M
--586.24M
65.23%547.07M
66.20%331.1M
--199.22M
Total assets
--2.64B
6.00%2.78B
45.25%2.62B
--2.42B
111.82%1.8B
39.86%851.02M
--608.47M
Liabilities
Current liabilities
Short term loan
--8.01M
--8.01M
----
----
----
----
----
Notes payable and accounts payable
--72.72M
41.38%83.99M
-28.88%59.4M
--64.67M
100.92%83.53M
96.15%41.57M
--21.2M
-Accounts payable
--72.72M
41.38%83.99M
-28.88%59.4M
--64.67M
100.92%83.53M
96.15%41.57M
--21.2M
Contract liabilities
--416.87M
-15.89%607.29M
35.18%722M
--580.57M
56.57%534.11M
24.49%341.14M
--274.03M
Advance receipts
--4.01M
0.00%4.01M
--4.01M
--4.01M
----
----
---9.96M
Salaries payable
--37.63M
33.72%75.18M
4.72%56.22M
--45.22M
77.00%53.69M
34.61%30.33M
--22.53M
Taxs payable
--8.58M
-46.97%4.36M
-21.83%8.23M
--10.48M
99.40%10.53M
66.93%5.28M
--3.16M
Other payable (including interest and dividends)
--88.77M
123.40%72.93M
22.68%32.64M
--42.64M
212.26%26.61M
-56.38%8.52M
--19.54M
-Other payable
--88.77M
123.40%72.93M
22.68%32.64M
--42.64M
212.26%26.61M
-56.38%8.52M
--19.54M
Non current liabilities due within one year
--26.1M
33.11%23.39M
-69.16%17.57M
--59.11M
753.35%56.97M
221.24%6.68M
--2.08M
Other current liabilities
--1.92M
32.50%2.15M
1,206.95%1.62M
--161.55K
--123.88K
----
----
Total current liabilities
--664.62M
-2.26%881.31M
17.78%901.71M
--806.87M
76.59%765.57M
30.35%433.53M
--332.58M
Current liabilities
Estimate liabilities
--1.39M
--761.78K
----
----
-98.58%2.79K
-75.42%197.15K
--802.05K
Long term deferred income
--35.14M
-15.25%38.78M
5.58%45.76M
--34.26M
-18.37%43.34M
35.73%53.1M
--39.12M
Lease liabilities
--207.65M
-6.16%215.1M
-4.20%229.23M
--240.39M
131.67%239.28M
--103.28M
----
Total non current liabilities
--244.18M
-7.40%254.65M
-2.70%274.99M
--274.66M
44.51%282.62M
125.00%195.57M
--86.92M
Total liabilities
--908.8M
-3.46%1.14B
12.26%1.18B
--1.08B
66.62%1.05B
49.96%629.1M
--419.5M
Shareholders equity
Paid-in capital
--105.73M
0.00%105.73M
21.36%105.73M
--105.73M
46.89%87.13M
0.00%59.31M
--59.31M
Capital reserve funds
--1.11B
1.52%1.1B
118.68%1.08B
--1.05B
299.41%494.39M
9.71%123.78M
--112.83M
Surplus reserve funds
--27.87M
29.73%27.87M
48.24%21.49M
--16.39M
64.99%14.5M
55.55%8.79M
--5.65M
Retained profit
--482.59M
94.55%386.95M
96.98%198.89M
--133.32M
236.13%100.97M
168.82%30.04M
--11.17M
Other composite income
---32.6K
----
----
----
----
----
----
Shareholders equity without minority interests
--1.72B
14.98%1.62B
101.90%1.41B
--1.3B
214.07%696.99M
17.44%221.92M
--188.96M
Minority interests
--13.55M
-37.65%21.42M
-40.19%34.35M
--37.97M
--57.43M
----
----
Total shareholder equity
--1.74B
13.73%1.64B
91.09%1.44B
--1.34B
239.95%754.41M
17.44%221.92M
--188.96M
Total liabilityies and equity
--2.64B
6.00%2.78B
45.25%2.62B
--2.42B
111.82%1.8B
39.86%851.02M
--608.47M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
(Q6)Jun 30, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Money funds --988.48M-7.69%1.16B96.42%1.25B--1.14B221.58%638.77M-5.63%198.64M--210.48M
Notes receivable and accounts receivable --228.3M24.31%223.82M66.96%180.06M--146.25M238.95%107.84M-18.87%31.82M--39.22M
-Notes receivable ------11.21M---------38.78%1.34M--2.19M----
-Accounts receivable --228.3M18.08%212.62M69.06%180.06M--146.25M259.47%106.5M-24.45%29.63M--39.22M
Other receivables (including interest and dividends) --18.68M193.95%17.81M-56.22%6.06M--5.63M277.16%13.84M12.45%3.67M--3.26M
-Other receivable --18.68M193.95%17.81M-56.22%6.06M--5.63M277.16%13.84M12.45%3.67M--3.26M
Contractual assets --85.73M4.31%50.09M51.66%48.02M--44.13M108.17%31.66M37.21%15.21M--11.08M
Advance payment --12.54M-48.07%12.86M-33.90%24.77M--68.42M24.43%37.47M660.14%30.12M--3.96M
Inventories --379.86M4.30%510.54M23.34%489.47M--423M86.32%396.85M84.19%212.99M--115.63M
Other current assets --14.45M30.27%12.64M-66.64%9.7M--10.4M5.88%29.09M7.31%27.48M--25.6M
Total current assets --1.73B-1.33%1.99B60.31%2.01B--1.84B141.49%1.26B27.04%519.92M--409.25M
Non Current assets
Fixed assets --213.27M5.24%219.13M20.33%208.23M--187.59M32.67%173.06M22.68%130.44M--106.32M
Constru in process --202.23M14,621.89%40.75M-7.39%276.77K--10.82M--298.87K--------
Productive biological assets --25.61M48.08%28.31M-37.26%19.12M--24.58M70.66%30.47M--17.86M----
Intangible assets --107.37M903.73%109.47M102.32%10.91M--6.36M63.24%5.39M-21.06%3.3M--4.18M
Long deferred expense --73.73M-5.57%77.02M10.56%81.57M--70.7M-6.71%73.78M-6.77%79.08M--84.82M
Deferred tax assets --15.02M69.81%13.21M2.57%7.78M--10.2M76.85%7.58M324.42%4.29M--1.01M
Usufruct assets --187.34M-8.26%198.98M-9.57%216.9M--230.04M161.86%239.86M--91.6M----
Other non current assets --92.35M68.92%102.57M265.26%60.72M--45.97M266.27%16.62M57.35%4.54M--2.88M
Total non current assets --916.92M30.38%789.45M10.68%605.51M--586.24M65.23%547.07M66.20%331.1M--199.22M
Total assets --2.64B6.00%2.78B45.25%2.62B--2.42B111.82%1.8B39.86%851.02M--608.47M
Liabilities
Current liabilities
Short term loan --8.01M--8.01M--------------------
Notes payable and accounts payable --72.72M41.38%83.99M-28.88%59.4M--64.67M100.92%83.53M96.15%41.57M--21.2M
-Accounts payable --72.72M41.38%83.99M-28.88%59.4M--64.67M100.92%83.53M96.15%41.57M--21.2M
Contract liabilities --416.87M-15.89%607.29M35.18%722M--580.57M56.57%534.11M24.49%341.14M--274.03M
Advance receipts --4.01M0.00%4.01M--4.01M--4.01M-----------9.96M
Salaries payable --37.63M33.72%75.18M4.72%56.22M--45.22M77.00%53.69M34.61%30.33M--22.53M
Taxs payable --8.58M-46.97%4.36M-21.83%8.23M--10.48M99.40%10.53M66.93%5.28M--3.16M
Other payable (including interest and dividends) --88.77M123.40%72.93M22.68%32.64M--42.64M212.26%26.61M-56.38%8.52M--19.54M
-Other payable --88.77M123.40%72.93M22.68%32.64M--42.64M212.26%26.61M-56.38%8.52M--19.54M
Non current liabilities due within one year --26.1M33.11%23.39M-69.16%17.57M--59.11M753.35%56.97M221.24%6.68M--2.08M
Other current liabilities --1.92M32.50%2.15M1,206.95%1.62M--161.55K--123.88K--------
Total current liabilities --664.62M-2.26%881.31M17.78%901.71M--806.87M76.59%765.57M30.35%433.53M--332.58M
Current liabilities
Estimate liabilities --1.39M--761.78K---------98.58%2.79K-75.42%197.15K--802.05K
Long term deferred income --35.14M-15.25%38.78M5.58%45.76M--34.26M-18.37%43.34M35.73%53.1M--39.12M
Lease liabilities --207.65M-6.16%215.1M-4.20%229.23M--240.39M131.67%239.28M--103.28M----
Total non current liabilities --244.18M-7.40%254.65M-2.70%274.99M--274.66M44.51%282.62M125.00%195.57M--86.92M
Total liabilities --908.8M-3.46%1.14B12.26%1.18B--1.08B66.62%1.05B49.96%629.1M--419.5M
Shareholders equity
Paid-in capital --105.73M0.00%105.73M21.36%105.73M--105.73M46.89%87.13M0.00%59.31M--59.31M
Capital reserve funds --1.11B1.52%1.1B118.68%1.08B--1.05B299.41%494.39M9.71%123.78M--112.83M
Surplus reserve funds --27.87M29.73%27.87M48.24%21.49M--16.39M64.99%14.5M55.55%8.79M--5.65M
Retained profit --482.59M94.55%386.95M96.98%198.89M--133.32M236.13%100.97M168.82%30.04M--11.17M
Other composite income ---32.6K------------------------
Shareholders equity without minority interests --1.72B14.98%1.62B101.90%1.41B--1.3B214.07%696.99M17.44%221.92M--188.96M
Minority interests --13.55M-37.65%21.42M-40.19%34.35M--37.97M--57.43M--------
Total shareholder equity --1.74B13.73%1.64B91.09%1.44B--1.34B239.95%754.41M17.44%221.92M--188.96M
Total liabilityies and equity --2.64B6.00%2.78B45.25%2.62B--2.42B111.82%1.8B39.86%851.02M--608.47M
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg